Propagator Ventures

Propagator Ventures is an Oslo-based venture capital firm founded in 2018, focusing on early-stage investments in deep tech startups. The firm is dedicated to bringing breakthrough science and engineering innovations to market, particularly in areas such as quantum computing, artificial intelligence, advanced materials, and computational biology. Propagator Ventures invests in companies that are developing transformational technologies with the potential to address some of the world's most pressing challenges. Their portfolio includes a range of innovative startups like Genesis Therapeutics, which is at the intersection of AI and biotech for drug discovery, and Universal Quantum, which is working on modular quantum computing hardware. The firm is particularly active in the Seed and Series A stages, with a strong presence in sectors like semiconductors, robotics, and high-tech computing. The team at Propagator Ventures includes experienced partners and advisors who are deeply embedded in the scientific and technological communities, helping to guide startups from early-stage development to scalable enterprises. The firm’s approach is collaborative, often co-investing with other leading venture funds to maximize the impact and growth potential of their portfolio companies. Their investments are globally oriented, with significant activity in the U.S., Europe, and Japan.